Literature DB >> 7284054

Platelet aggregation and reversible platelet aggregates in type I-diabetes staged by retinal fluorescein angiography.

K Silberbauer, G Schernthaner, H Sinzinger, H Freyler.   

Abstract

In 70 patients with juvenile-onset, insulin-dependent (type I) diabetes and 75 age- and sex-matched controls the reversible platelet aggregates expressed as platelet count ratio (PCR) and the ADP-induced platelet aggregation were studied. Retinal microangiopathy was staged by retinal fluorescein angiography. The mean PCR of the patients (0.82 +/- 0.02) was statistically significantly lower than that of the controls (0.97 +/- 0.01). However, in different stages of retinopathy no significantly different PCR could be observed. ADP-induced platelet aggregation (0.5 and 1.0 micromol/l) exhibited a higher reactivity of diabetic platelets, but with the exception of tangent alpha (see later), the differences were not statistically significant in comparison to the controls. After collagen-induced platelet aggregation (0.5 and 1 microgram/ml) the lag time in diabetics was significantly (p less than 0.001) lower than in the controls, whereas the other quantitative parameters exhibited higher platelet reactivity in general, though not statistically significant. No relationship between PCR and the in vitro induced aggregation was found. The degree of retinopathy had no significant influence on platelet aggregation. In general, the data demonstrate an increase in sensitivity of platelets in juvenile-onset diabetics, whereas no influence of stage of microangiopathy could be detected.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7284054     DOI: 10.1016/0021-9150(81)90126-x

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  4 in total

1.  Increased platelet thromboxane receptor sensitivity in diabetic patients with proliferative retinopathy.

Authors:  A Collier; P Tymkewycz; R Armstrong; R J Young; R L Jones; B F Clarke
Journal:  Diabetologia       Date:  1986-08       Impact factor: 10.122

2.  Increased platelet aggregability in diabetic children: relation to serum lipid and fatty acid composition.

Authors:  U Ewald; M Kobbah; B Vessby; T Tuvemo
Journal:  Diabetologia       Date:  1983-11       Impact factor: 10.122

3.  Epoprostenol (prostacyclin, PGI2) binding and activation of adenylate cyclase in platelets of diabetic and control subjects.

Authors:  G L Shepherd; P J Lewis; I A Blair; C de Mey; J MacDermot
Journal:  Br J Clin Pharmacol       Date:  1983-01       Impact factor: 4.335

4.  Quantitative dynamics of reversible platelet aggregation: mathematical modelling and experiments.

Authors:  Aleksandra A Filkova; Alexey A Martyanov; Andrei K Garzon Dasgupta; Mikhail A Panteleev; Anastasia N Sveshnikova
Journal:  Sci Rep       Date:  2019-04-17       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.